AMST
Amesite Inc.
Price Chart
Latest Quote
$1.80
Current Price| Previous Close | $1.83 |
| Open | $1.82 |
| Day High | $1.86 |
| Day Low | $1.76 |
| Volume | 23,901 |
Stock Information
| Shares Outstanding | 4.57M |
| Cash Equivalents | $1.83M |
| Revenue | $194K |
| Net Income | $-3.35M |
| Sector | Technology |
| Industry | Software - Application |
| Market Cap | $8.23M |
| EPS (TTM) | $-0.83 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | 0.13 |
| Debt to Earnings | -0.10 |
| Current Ratio | 6.79 |
| Quick Ratio | 6.52 |
| Avg Revenue Growth | -21.04% |
| Profit Margin | -3274.60% |
| Return on Equity | -132.08% |
| Avg FCF Growth | -15.46% |
| FCF Yield | -34.43% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $1.80 | 24,000 |
| 2026-01-30 | $1.83 | 23,400 |
| 2026-01-29 | $1.85 | 28,600 |
| 2026-01-28 | $1.93 | 15,300 |
| 2026-01-27 | $2.01 | 47,200 |
| 2026-01-26 | $2.11 | 94,300 |
| 2026-01-23 | $2.04 | 18,100 |
| 2026-01-22 | $1.99 | 9,100 |
| 2026-01-21 | $1.99 | 27,400 |
| 2026-01-20 | $2.01 | 7,300 |
| 2026-01-16 | $2.10 | 17,100 |
| 2026-01-15 | $2.11 | 21,800 |
| 2026-01-14 | $2.12 | 38,600 |
| 2026-01-13 | $1.94 | 11,000 |
| 2026-01-12 | $1.98 | 10,000 |
| 2026-01-09 | $1.97 | 21,100 |
| 2026-01-08 | $1.96 | 16,600 |
| 2026-01-07 | $2.01 | 17,000 |
| 2026-01-06 | $1.97 | 30,300 |
| 2026-01-05 | $2.06 | 12,000 |
About Amesite Inc.
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
đ° Latest News
Amesite introduces AI-native EMR system, NurseMagic EMR
Hospital Management âĸ 2025-12-22T13:51:37Z
Amesite Insiders Added US$1.26m Of Stock To Their Holdings
Simply Wall St. âĸ 2025-08-06T12:31:47Z
Amesite Third Quarter 2025 Earnings: US$0.16 loss per share (vs US$0.56 loss in 3Q 2024)
Simply Wall St. âĸ 2025-05-17T12:23:54Z
Amesite Inc. (AMST): Revolutionizing Hospice Care with AI-Driven NurseMagic
Insider Monkey âĸ 2025-03-06T17:02:43Z
Amesite Inc. (AMST) Accelerates NurseMagic Sales with 95% Faster Enterprise Onboarding
Insider Monkey âĸ 2025-02-26T12:39:14Z
Income Statement (Annual)
Revenue
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $110,459 | $166,881 | $845,009 | $697,001 |
| Operating Revenue | $110,459 | $166,881 | $845,009 | $697,001 |
Expenses
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Expenses | $3,714,072 | $4,746,532 | $5,069,517 | $9,753,519 |
| Other Income Expense | $-90,869 | - | $-1,619 | $-12,635 |
| Net Non Operating Interest Income Expense | $77,396 | $176,469 | $71,205 | $9,230 |
| Operating Expense | $3,714,072 | $4,746,532 | $5,069,517 | $9,753,519 |
| Selling And Marketing Expense | $545,030 | $763,915 | $1,053,193 | $1,509,694 |
| General And Administrative Expense | $2,477,888 | $2,908,289 | $2,492,777 | $5,183,863 |
| Interest Expense | - | $0 | $1,619 | $12,635 |
| Interest Expense Non Operating | - | $0 | $1,619 | $12,635 |
| Other Non Operating Income Expenses | - | - | $-1,619 | $-12,635 |
Income & Earnings
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Net Interest Income | $77,396 | $176,469 | $71,205 | $9,230 |
| Interest Income | $77,396 | $176,469 | $72,824 | $9,230 |
| Normalized Income | $-3,526,217 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Net Income From Continuing And Discontinued Operation | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Total Operating Income As Reported | $-3,603,613 | $-4,579,651 | $-4,224,508 | $-9,056,518 |
| Net Income Common Stockholders | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Net Income | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Net Income Including Noncontrolling Interests | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Net Income Continuous Operations | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Pretax Income | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Special Income Charges | $-90,869 | $0 | - | - |
| Interest Income Non Operating | $77,396 | $176,469 | $72,824 | $9,230 |
| Operating Income | $-3,603,613 | $-4,579,651 | $-4,224,508 | $-9,056,518 |
Per Share Metrics
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Diluted EPS | $-1.03 | $-1.73 | $-1.68 | $-4.67 |
| Basic EPS | $-1.03 | $-1.73 | $-1.68 | $-4.67 |
Other
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,078,941 | $-4,045,984 | $-3,469,201 | $-8,180,914 |
| Total Unusual Items | $-90,869 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-90,869 | $0 | - | - |
| Reconciled Depreciation | $433,803 | $533,667 | $682,483 | $875,604 |
| EBITDA (Bullshit earnings) | $-3,169,810 | $-4,045,984 | $-3,469,201 | $-8,180,914 |
| EBIT | $-3,603,613 | $-4,579,651 | $-4,151,684 | $-9,056,518 |
| Diluted Average Shares | $3,525,672 | $2,542,440 | $2,469,890 | $1,939,132 |
| Basic Average Shares | $3,525,672 | $2,542,440 | $2,469,890 | $1,939,132 |
| Diluted NI Availto Com Stockholders | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Impairment Of Capital Assets | $90,869 | $0 | - | - |
| Research And Development | $691,154 | $1,074,328 | $1,523,547 | $3,059,962 |
| Selling General And Administration | $3,022,918 | $3,672,204 | $3,545,970 | $6,693,557 |
| Other Gand A | $2,477,888 | $2,908,289 | $2,492,777 | $5,183,863 |
Balance Sheet (Annual)
Assets
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Net Tangible Assets | $2,214,699 | $1,870,884 | $5,305,979 | $7,069,078 |
| Total Assets | $3,097,099 | $3,314,177 | $6,349,752 | $8,883,860 |
| Total Non Current Assets | $663,240 | $809,612 | $867,412 | $1,153,864 |
| Other Non Current Assets | $100,000 | $100,000 | - | - |
| Goodwill And Other Intangible Assets | $523,804 | $644,828 | $778,446 | $1,066,674 |
| Other Intangible Assets | $523,804 | $644,828 | $778,446 | $1,066,674 |
| Current Assets | $2,433,859 | $2,504,565 | $5,482,340 | $7,729,996 |
| Other Current Assets | $94,100 | $403,489 | $106,679 | $560,084 |
| Receivables | $6,341 | $30,060 | $15,000 | $14,545 |
| Accounts Receivable | $6,341 | $30,060 | $15,000 | $14,545 |
| Cash Cash Equivalents And Short Term Investments | $2,333,418 | $2,071,016 | $5,260,661 | $7,155,367 |
| Cash And Cash Equivalents | $2,333,418 | $2,071,016 | $5,260,661 | $7,155,367 |
| Restricted Cash | - | $100,000 | $100,000 | - |
| Prepaid Assets | - | - | - | $560,084 |
Liabilities
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $358,596 | $798,465 | $265,327 | $748,108 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $358,596 | $798,465 | $265,327 | $748,108 |
| Current Deferred Liabilities | $36,745 | $0 | $53,958 | $342,672 |
| Payables And Accrued Expenses | $78,653 | $143,190 | $146,869 | $231,380 |
| Payables | $25,413 | $48,907 | $70,070 | $122,285 |
| Accounts Payable | $25,413 | $48,907 | $70,070 | $122,285 |
Equity
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Common Stock Equity | $2,738,503 | $2,515,712 | $6,084,425 | $8,135,752 |
| Total Equity Gross Minority Interest | $2,738,503 | $2,515,712 | $6,084,425 | $8,135,752 |
| Stockholders Equity | $2,738,503 | $2,515,712 | $6,084,425 | $8,135,752 |
| Retained Earnings | $-41,450,587 | $-37,833,501 | $-33,430,319 | $-29,277,016 |
Other
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Ordinary Shares Number | $4,572,713 | $2,542,440 | $2,542,440 | $2,166,123 |
| Share Issued | $4,572,713 | $2,542,440 | $2,542,440 | $2,166,123 |
| Tangible Book Value | $2,214,699 | $1,870,884 | $5,305,979 | $7,069,078 |
| Invested Capital | $2,738,503 | $2,515,712 | $6,084,425 | $8,135,752 |
| Working Capital | $2,075,263 | $1,706,100 | $5,217,013 | $6,981,888 |
| Total Capitalization | $2,738,503 | $2,515,712 | $6,084,425 | $8,135,752 |
| Additional Paid In Capital | $44,188,632 | $40,348,958 | $39,514,489 | $37,412,551 |
| Capital Stock | $458 | $255 | $255 | $217 |
| Common Stock | $458 | $255 | $255 | $217 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | $36,745 | $0 | $53,958 | $342,672 |
| Pensionand Other Post Retirement Benefit Plans Current | $243,198 | $655,275 | $64,500 | $174,056 |
| Current Accrued Expenses | $53,240 | $94,283 | $76,799 | $109,095 |
| Net PPE | $39,436 | $64,784 | $88,966 | $87,190 |
| Accumulated Depreciation | $-142,907 | $-117,559 | $-92,211 | $-66,864 |
| Gross PPE | $182,343 | $182,343 | $181,177 | $154,054 |
| Machinery Furniture Equipment | $182,343 | $182,343 | $181,177 | $154,054 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | $-2,833,548 | $-3,189,645 | $-3,645,209 | $-7,427,274 |
Operating Activities
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Operating Cash Flow | $-2,455,248 | $-2,813,779 | $-3,249,176 | $-6,715,652 |
| Cash Flow From Continuing Operating Activities | $-2,455,248 | $-2,813,779 | $-3,249,176 | $-6,715,652 |
| Operating Gains Losses | $95,984 | - | - | - |
Investing Activities
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Capital Expenditure | $-378,300 | $-375,866 | $-396,033 | $-711,622 |
| Investing Cash Flow | $-378,300 | $-375,866 | $-396,033 | $-711,622 |
| Cash Flow From Continuing Investing Activities | $-378,300 | $-375,866 | $-396,033 | $-711,622 |
| Capital Expenditure Reported | $-378,300 | $-374,700 | $-368,909 | $-695,047 |
Financing Activities
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $3,095,950 | $0 | $1,850,503 | $3,869,550 |
| Financing Cash Flow | $3,095,950 | $0 | $1,850,503 | $3,869,550 |
| Cash Flow From Continuing Financing Activities | $3,095,950 | $0 | $1,850,503 | $3,869,550 |
| Net Common Stock Issuance | $3,095,950 | $0 | $1,850,503 | $3,869,550 |
| Common Stock Issuance | $3,095,950 | $0 | $1,850,503 | $3,869,550 |
Other
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| End Cash Position | $2,433,418 | $2,171,016 | $5,260,661 | $7,155,367 |
| Beginning Cash Position | $2,171,016 | $5,360,661 | $7,055,367 | $10,713,091 |
| Changes In Cash | $262,402 | $-3,189,645 | $-1,794,706 | $-3,557,724 |
| Net PPE Purchase And Sale | $0 | $-1,166 | $-27,124 | $-16,575 |
| Purchase Of PPE | $0 | $-1,166 | $-27,124 | $-16,575 |
| Change In Working Capital | $515,129 | $221,267 | $-29,828 | $-122,368 |
| Change In Other Working Capital | $36,745 | $-53,958 | $-288,714 | $9,472 |
| Change In Payables And Accrued Expense | $145,276 | $587,095 | $-194,064 | $92,280 |
| Change In Accrued Expense | $168,770 | $608,258 | $-141,852 | $14,362 |
| Change In Payable | $-23,494 | $-21,163 | $-52,212 | $77,918 |
| Change In Account Payable | $-23,494 | $-21,163 | $-52,212 | $77,918 |
| Change In Prepaid Assets | $309,389 | $-296,810 | $453,405 | $-260,695 |
| Change In Receivables | $23,719 | $-15,060 | $-455 | $36,575 |
| Changes In Account Receivables | $23,719 | $-15,060 | $-455 | $36,575 |
| Other Non Cash Items | $-200,000 | - | $71,938 | $148,948 |
| Stock Based Compensation | $226,053 | $834,469 | $179,534 | $1,442,087 |
| Asset Impairment Charge | $90,869 | $0 | - | - |
| Depreciation Amortization Depletion | $433,803 | $533,667 | $682,483 | $875,604 |
| Depreciation And Amortization | $433,803 | $533,667 | $682,483 | $875,604 |
| Amortization Cash Flow | $408,455 | $508,318 | - | - |
| Amortization Of Intangibles | $408,455 | $508,318 | - | - |
| Depreciation | $25,348 | $25,349 | - | - |
| Gain Loss On Investment Securities | $95,984 | - | - | - |
| Net Income From Continuing Operations | $-3,617,086 | $-4,403,182 | $-4,153,303 | $-9,059,923 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |